CIK 0001175151 · Non-accelerated filer<br>Smaller reporting company
Cytosorbents Corp
Sign in to watch- Ticker
- CTSO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980373793
- Phone
- 973-329-8885
- Business address
- 305 COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- MedaSorb Technologies CORP, GILDER ENTERPRISES INC
- Open-market buys, last 90 days
- $120,435
- in 4 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$120,435. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-12-29 | Chan Phillip P. Chief Executive Officer | Purchase | +9,438 | $4.05 | $38K | 762,981 |
| 2021-12-10 | Chan Phillip P. Chief Executive Officer | Purchase | +5,000 | $5.25 | $26K | 753,443 |
| 2021-12-09 | Jones Edward Raymond Director | Option exercise | +4,000 | $4.13 | $17K | 82,800 |
| 2021-12-09 | Jones Edward Raymond Director | Shares withheld for taxes | −3,161 | $5.22 | $17K | 79,639 |
| 2021-12-09 | Jones Edward Raymond Director | Option exercise · Stock Option (right to buy) | −4,000 | 0 | ||
| 2021-11-23 | BLOCH KATHLEEN P. Chief Financial Officer | Purchase | +4,000 | $4.98 | $20K | 25,000 |
| 2021-08-31 | Kraus Al Director | Option exercise | +4,000 | $4.13 | $17K | 129,046 |
| 2021-08-31 | Kraus Al Director | Sale | −4,000 | $9.40 | $38K | 125,046 |
| 2021-08-31 | Kraus Al Director | Option exercise · Stock Option (right to buy) | −4,000 | 0 | ||
| 2021-04-12 | Sobel Alan D. Director | Grant or award · Stock Option (right to buy) | +17,250 | 17,250 | ||
| 2021-04-12 | Kraus Al Director | Grant or award · Stock Option (right to buy) | +34,500 | 34,500 | ||
| 2021-04-12 | Jones Edward Raymond Director | Grant or award · Stock Option (right to buy) | +17,250 | 17,250 | ||
| 2021-04-12 | Deliargyris Efthymios Chief Medical Officer | Grant or award | +40,000 | $8.99 | $360K | 183,000 |
| 2021-04-12 | Deliargyris Efthymios Chief Medical Officer | Grant or award · Stock Option (right to buy) | +63,250 | 63,250 | ||
| 2021-04-12 | Chan Phillip P. Chief Executive Officer | Grant or award | +72,000 | $8.99 | $647K | 769,339 |
| 2021-04-12 | Chan Phillip P. Chief Executive Officer | Grant or award · Stock Option (right to buy) | +96,000 | 96,000 | ||
| 2021-04-12 | Capponi Vincent President | Grant or award | +62,215 | $8.99 | $559K | 467,756 |
| 2021-04-12 | Capponi Vincent President | Grant or award · Stock Option (right to buy) | +78,200 | 78,200 | ||
| 2021-04-12 | BLOCH KATHLEEN P. Chief Financial Officer | Grant or award | +49,450 | $8.99 | $445K | 375,372 |
| 2021-04-12 | BLOCH KATHLEEN P. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +69,000 | 69,000 |
Page 10 of 39 · 774 trades